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Abstract 
The goal of this research was to develop a mutant 
glutamine synthetase (GS) containing plasmid that could be 
used as an internal control for comparisons between in vivo 
and in vitro conditions for RNA yield, for loading control 
purposes in gel analysis, and for quantitation purposes. 
The hypothesis is that mouse embryo development in CZB 
medium, which promotes preimplantation mouse embryo 
development, mimics in vivo conditions in the mouse. A 
mutant plasmid was successfully created using the 
-- restriction enzyme Bsml to shorten the plasmid by 489 bp. 
The RT-PCR product from the RNA transcribed by the mutant 
internal control plasmid will be easily distinguishable from 
endogenous and control tissue products resulting from DNA 
contamination. Experiments can now be performed, with the 
critical quality control check available in the mutant 
plasmid, that will help to characterize the expression of 
the GS gene in preimplantation mouse embryo development . 
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Introduction 
Preimplantation Mouse Embryo Development 
Embryogenesis is a very complex and dynamic process. 
Although the majority of this development occurs 
postimplantation l it must be remembered that the foundation 
for this miraculous process is laid down before implantation 
into the uterine wall. Preimplantation development is in 
itself a highly intricate process. 
The start of embryonic development commences upon the 
fusion of the egg and sperm to form a zygote. For the 
mouse l it ends approximately nineteen days later at 
parturition. Only during 14.5 of those days is the embryo 
attached to the uterine wall. By the time it reaches the 
uterus I the embryo has already made many cell 
differentiations. Not only has the cell lineage developed 
that will form the embryo properl but the cell lineages that 
will form the placenta and extraembryonic yolk sac 1 both 
which are necessary for successful implantation and 
interaction with mother I have also emerged. (Hogan 1986) 
After fertilization has occurred I the zygote undergoes 
a process of rapid cell division without growth called 
cleavage. Typical of mammalian development I mouse cleavage 
is slower than in most organisms. The embryo 1S essentially 
independent of the mother during cleavage and so must rely 
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heavily on stored maternal proteins and RNAs until its own 
genes are turned on. In most organisms, this does not occur 
until after cleavage. Mammals are the exception, having the 
transition from maternal genetic control to embryonic 
genetic control complete by one to three cleavage divisions 
(Kidder 1993). This activation of zygotic genes occurs at 
the mid-two-cell stage for the mouse, approximately 27 hr 
postfertilization (Hogan 1986) . 
This conversion from relying on stored maternal mRNA to 
relying on embryonic transcription exhibits a typical 
pattern of mRNA levels. The mRNA level of a specific gene 
first sharply decreases after fertilization, but 
subsequently increases again. In the mouse, the low point 
generally occurs in the late 2-cell stage. The decline is 
due to the degradation of maternal mRNAsi the rise is due to 
embryonic transcription. Levels of mRNA for histone 
decrease by 80-90% after fertilization, but increase again 
maintaining a constant number of mRNAs per cell until the 
blastocyst stage. Another example is the expression of 
actin mRNA, which upon decreasing, rises again to a 60-fold 
level by early blastocyst. (Kidder 1993) 
This change in genomic utilization from stored maternal 
mRNAs to zygotic genes is partly responsible for the change 
in the pattern of RNA and protein synthesis observed in the 
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cleaving embryo. Much of these changes can be correlated 
with DNA synthesis, cell division, and commitment of cells 
to developmental fates. Some of the specific processes 
probably responsible for the changes in protein synthesis 
after fertilization are increased turnover rates, post-
translational modification, selective use of specific 
maternal mRNAs, specific degradation of maternal mRNAs, and 
synthesis of proteins from zygotic genes. All of these 
changes reflect the shifting needs of the developing embryo. 
(Hogan 1986) 
A very important phenomenon occurs at the 8-cell stage 
of mammalian preimplantation development called compaction. 
After the third cleavage is complete, the blastomeres or 
cleavage-stage cells rearrange to form a compact sphere of 
cells. The inside of the sphere is sealed off by the 
formation of surface tight junctions. Compaction allows for 
maximum contact between cells and eventually brings about 
the separation of the trophoblast from the inner cell mass. 
(Gilbert 1994) 
Compaction 1S the result of the polarization of 
blastomeres early in the 8-cell stage (Gilbert 1994) 
Polarization involves dramatic changes within the eight 
cells detectable in both the cytoskeletal and cytoplasmic 
components. Microtubule organizing centers (MTOCs), actin, 
-clathrin, and endosomes migrate to the apical or outward-
facing pole of the cell. The cell nucleus moves in the 
opposite direction or basally. The apical pole possesses 
long microvilli. (Johnson and Maro 1986) 
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Corresponding to the histological differences between 
the poles are physiological differences. The apical end has 
a much higher rate of endocytosis of macromolecules. Much 
greater adhesiveness is present at the apical end of the 
cells, ensuring that the pole faces outward. Evidence 
points to these changes in cell architecture during 
polarization as being responsible for compaction. (Johnson 
and Maro 1986) 
The development of polarity is stable. It is carried 
through the subsequent cleavage to the 16-cell stage. The 
consequence is that the daughter cells may inherit different 
make-ups of the parental polar cell, thus forming the first 
heterogeneity between cells. The sum result of polarization 
and compaction is a 16-cell morula. One to two internal 
cells and a larger group of external cells, which give rise 
to the trophoectoderm, make up the morula. (Johnson and 
Maro 1986) 
By the 64-cell stage, the trophoectoderm and the inner 
cell mass have separated into layers (Gilbert 1994). 
Cleavage ends with the generation of a blastocyst, which 
--
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consists of a hollow vesicle of trophoectoderm surrounding a 
fluid-filled cavity and a small number of ICM (Inner Cell 
Mass) cells. These ICM cells are the cells that actually 
give rise to the organism. At 4.5 days post-fertilization, 
the blastocyst implants itself into the uterine wall to regain 
the necessary dependence on the mother. (Hogan 1986) 
As a side note, it is during the murine 8-cell stage that 
the metabolic preference for energy substrates begins to change. 
Before the 16-cell stage or morula formation, pyruvate is 
preferred as the energy substrate. By blastocyst formation, 
glucose is the preferred energy source. Both lactate and 
pyruvate may be supplied by cumulus cells and oviductal 
secretions. Although high concentrations of glucose are still 
required for the blastocyst to hatch from the zona pellucida, a 
variety of energy sources can support development after the 8-
cell stage. (Kaye 1986) 
Glutamine Synthetase (GS) 
GS is responsible for making glutamine in the cell (fig.1). 
It catalyzes the reversible coupling of two reactions. One is 
the endergonic synthesis of glutamine from glutamate and ammonia. 
The other is the exergonic hydrolysis of ATP to ADP and inorganic 
phosphate. This hydrolysis releases enough energy to make the 
endergonic production of glutamine energetically favorable. 
(Meister 1985, Cooper 1988) 
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Fig. 1. Amidation of glutamate to form glutamine with concomitant 
hydrolysis of ATP. (Stryer 1988) 
OVerall Mechanism 
GS has separate binding sites for glutamate, ATP, and 
ammonia; binding is in 'a non-covalent manner (Cooper 1988) . 
Glutamate attaches to GS in a fully extended conformation (Cooper 
1988) in which the a-hydrogen of glutamate is directed away from 
the enzyme (Meister 1985). The reaction occurs through the 
formation of enzyme-bound intermediates, including a complex of 
enzyme, gamma-glutamyl phosphate, and ADP (Meister 1985). The 
final production of glutamine is due to the nucleophilic attack 
,by ammonia to displace inorganic phosphate. The reaction only 
proceeds in the presence of a divalent metal cation (Cooper 
1988) . 
Properties 
GS is very specific for ATP. Only dATP produces activity 
comparable to that observed with ATP. The specificity for a 
nucleophile is much less stringent. In addition to ammonia, 
other nucleophiles such as hydroxylamine, hydrazine, monomethyl 
hydrazine, methylamine, ethylamine, and glycine ethyl ester can 
be used. Instead of glutamine forming when these nucleophiles 
.-
-. 
The isolated rat liver GS has a KIn value for L-glutamate 
around 5 mM. The KIn value for ATP (with Mg2+) is approximately 
2.3 mM. Optimal activity is around pH 7.0-7.4. (Meister 1985) 
Molecular Characterization 
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First isolated from sheep brain, the enzyme has now been 
isolated from man, rat, and pig brain, from chicken, rat and 
chinese hamster liver, from chick neural retina, and from rat 
spleen. Mammalian GS is highly preserved in amino acid 
composition, subunit structure, and molecular weight. Mammalian 
GS is composed of eight seemingly identical subunits with 
molecular weights between 44,000 and 49,000. The rat liver GS 
has a molecular weight of 360,000. (Meister 1985) 
Genetic Origin 
Different tissue-specific patterns of mRNA expression of GS 
have been observed. Magnuson and Young (1988) found that GS does 
not have tissue-specific genes responsible for the expression 
differences. Instead, it was discovered that GS is derived from 
a single gene which gives rise to the observed tissue-specific 
mRNA patterns. Another words, it is the same gene giving rise to 
all the different mRNA patterns observed; mUltiple genes for GS 
do not exist. 
Both the cDNA and genomic DNA of GS have been isolated and 
cloned. Magnuson and Young have cloned and characterized the 
murine GS gene. A UEMBL-3 genomic library was created from R200 
cell DNA. The library was screened with pMGS1. A total of seven 
overlapping genomic clones encoding the murine GS were obtained. 
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The nucleotide sequence for glutamine synthetase mRNA has 
been determined by Hayward et al. (1986) from Chinese hamster 
cells using cDNA clones from pBR322 and lambda-gt10 libraries 
with primer extension. cDNA is complementary DNA synthesized by 
reverse transcriptase from a mRNA template and thus contains no 
introns. The obtained sequence contained approximately 1400 base 
pairs. 
Bhandari et al. (1988) have also analyzed the nucleotide 
sequence of GS from murine 3T3-L1 pre-adipocytes. Two separate 
genomic libraries in aEMBL-3 were utilized. The 1.9 Kb Sal1-
EcoR1 restriction fragment of the GS genomic clone was analyzed 
using the dideoxynucleotide chain-termination method. The 
genomic fragment was composed of 1851 base pairs, including the 
first exon, 1029 bp of the 5' flanking sequence, and 600 bp of 
the 3' flanking sequence. 
Biological Roles 
The importance of GS in cells stems from glutamine's 
versatile metabolic functions. Glutamine is an efficient, non-
toxic way to store nitrogen and glutamate, both of which can 
easily be recovered. Ammonia is toxic to many animal tissues 
(Cooper 1988), and both ammonia and glutamic acid, the major 
neurotransmitter, are toxic to nervous tissue (Magnuson and Young 
1988). Because of this, GS is a critical element in nitrogen 
metabolism (Stryer 1988) . 
Glutamine and its precursor, glutamate, are the two main 
participants in the assimilation of nitrogen into biomolecules. 
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Glutamate dehydrogenase catalyzes the synthesis of glutamate from 
ammonium ion (NH/) and a-ketoglutarate, a TCA cycle i.ntermediate 
(Stryer 1988). Glutamate donates its amino group to various 
metabolic pathway intermediates to form many of the twenty amino 
acids via transamination. Glutamine, an amino acid itself, is 
synthesized in a reversible reaction from glutamate and NH3+ as 
previously discussed. GS is thus a major linkage point between 
amino acid metabolism and the TCA cycle (Hayward et al. 1985). 
Glutamine donates its side-chain nitrogen to help make a variety 
of important compounds, including purine rings, NAD+, asparagine, 
tryptophan, the imidazole ring of histidine, glucosamine-6-
phospate, guanine, CTP, ATP, and carbamoyl phosphate (Stryer 
--I 1988). Carbamoyl phosphate is used to make urea and pyrimidine 
rings (Cooper 1988) . 
-
Glutamine's versatility is not limited to solely being a 
nitrogen donor. Glutamine is additionally utilized as an energy 
substrate in a variety of tissues, including the small intestine, 
bone, diploid fibroblasts, HeLa cells, and possibly the brain. 
Glutamine is also a building block for most proteins (Cooper 
1988) . 
Regulation 
The level of GS activity in cells is highly dependent on 
hormones (Cooper 1988). According to a study by Bhandari et al. 
(1988) on murine 3T3-L1 adipocytes, hydrocortisone increases the 
biosynthetic rate of GS and insulin decreases the biosynthetic 
rate. 
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When not under the influence of hormones, however, the cell 
must continue to monitor GS activity. A highly efficient system 
is present in the cell. GS is inhibited by carbamoyl phosphate 
(Cooper 1988). As mentioned earlier, carbamoyl phosphate lS a 
product derived from glutamine. If there are high levels of 
carbamoyl phosphate in the cell, it indicates that there is no 
need for more glutamine production. This feedback mechanism 
helps control the levels of product made from glutamine. 
GS is also inhibited by phosphate (Cooper 1988). This is a 
reciprocal control involving the enzyme glutaminase. Glutaminase 
essentially does the opposite job of GS; it catalyzes the 
hydrolytic cleavage of glutamine back to glutamate (Niklas 1988). 
Since glutaminase is activated by phosphate, GS inhibition by 
phosphate prevents the wasteful, simultaneous action of both 
enzymes. 
Although the above held true for both brain and liver 
enzymes, some tissue-specific regulatory differences do exist. 
Rat liver GS is greatly inhibited by glycine, alanine, and 
serine. The sheep brain GS is not affected by these molecules, 
and the rat brain GS is only slightly inhibited (Cooper 1988). 
Only the liver GS is highly activated by a-ketoglutarate. 
Recall that glutamate is made from this TCA cycle intermediate, 
and glutamate is the direct precursor to glutamine. This is a 
feed-forward activation (Cooper 1988) . 
13 
In vitro Preimplantation Development 
Most research in embryology and developmental biology is 
done after the implantation of the embryo; however, much of the 
foundation for proper embryonic development is laid down before 
preimplantation. Chatot et al. (1989) have developed a CZB 
medium that allows in vitro development of preimplantation mouse 
embryos. CZB medium and a glucose washing procedure allow the 
development of 1-cell embryos to the blastocyst stage in mouse 
embryos that usually exhibit a 2-cell block during in vitro 
development (Chatot 1989). 
Glutamine is an essential ingredient in CZB medium, with an 
optimal concentration of 1 rnM. Glutamine has been demonstrated 
by Chatot et al. (1989) to promote embryo development between the 
1-cell and 4-cell stages, but glutamine is not required for 
complete development after the 4-cell stage. Chatot et al. 
(1990) have also exhibited that glutamine is utilized as an 
energy substrate by the preimplantation mouse embryo. It is 
oxidized to CO2 through the TCA cycle. 
The present investigation is one in a series of studies with 
the goal of optimizing preimplantation mouse embryo development 
in culture and defining a set of testable parameters for normal 
development. This would allow the study of the effects of 
specific teratogens on the embryo. The hypothesis is that mouse 
embryo development in CZB medium mimics in vivo conditions ln the 
mouse. If this is a true assessment, the expression of the 
-. -
enzymes for glutamine metabolism should be similar for both in 
vivo and in vitro grown embryos. 
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The purpose of the present study was to develop a mutant 
internal control RNA for GS. Once made, the GS control will be 
used in comparison between in vivo and in vitro conditions for 
RNA yield, for a loading control in gel analysis, and for 
quantitation purposes in experiments that will help to 
characterize the expression of the GS gene in preimplantation 
mouse development . 
-. 
I 
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Methods and Materials 
Restriction Enzyme Digest 
The linearization of the pBB3.2 GS plasmid, obtained from 
the laboratory of Magnuson and Young, was carried out in a 0.5 ml 
microcentrifuge tube containing the following: 1 ~g DNA (2 ~l), 
1.5 ~l (10% total volume) appropriate restriction buffer, 0.5-1.0 
~l restriction enzyme, and 11 ~l nuclease free water (Promega 
Corp.) to bring the total volume to approximately 15 ~l. The 
restriction enzyme was always added last, and all digests were 
run for 60-80 minutes. 
Bsm1 was obtained from New England Biolabs supplied at 5,000 
U/ml in 50 mM KCl, 10 mM Tris-HCl (pH 7.4), 0.1 mM EDTA, 1 mM 
DTT, 200 ~g/ml BSA, and 50% glycerol. NEBuffer 2 was supplied 
with Bsm1 as a lOX concentrated stock. The working 
concentration, lX, contained 50 mM NaCl, 10 mM Tris-HCl, 10 mM 
MgC1 2 , and 1 mM DTT all at pH 7.9. Bsm1 digests were run in a 65 
water bath. 
Kpn1 (New England Biolabs) was supplied in the same solution 
as Bsm1. Kpn1 digests were run at 37°C with NEBuffer 1 as the 
restriction buffer. 
EcoR1, also from NEB, was run with NEBuffer EcoR1 at 37°C 
Agarose Gel Electrophoresis 
SeaKem LE agarose (Midwest Scientific) was used to make 0.7% 
and 2.0% gels. At least 1 h. after pouring, 1X TBE (10.8 g Tris-
-. base, 5.5 g boric acid, 20 ml 0.5 M EDTA pH 8.0, and dH20 to I 
bring to 0.5 1) with 250 ~g/volume EtBr was added. Gel wells 
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were then loaded. Minigels were run using 0.5-1.0 ~g DNA, 1X 
loading buffer at 10% total volume [lOX = 20% glycerol, 0.1% 
bromophenol blue, and 0.1% EDTA (pH 7.5)], and 9-13 ~l TE buffer 
(pH 8.0; 10 mM Tris-HCl and 1 mM EDTA). Gels were run at 
approximately 20 volts/em. 2% gels were used for analysis of PCR 
products. Low-melt gels were run at 0.7% low-melt agarose ln the 
cold at approximately 10 volts/em. Gels were viewed under 
ultraviolet light to visualize the EtBr stained bands. 
Wizard Miniprep 
Approximately 1 ~g of the large Bsm1 DNA fragment (without 
the 489 bp fragment) was excised from a low-melt gel and 
transferred to a 0.5 ml microcentrifuge tube. After the agarose 
was allowed to melt, 1 ml of Wizard PCR Preps DNA purification 
resin (Promega Corp.) was added and mixed by vortexing for one 
minute. This solution with bound DNA was then pipetted into a 
syringe barrel and pushed into a mini-column. The mini-column 
was subsequently washed with 2 ml of Wizard PCR Preps column wash 
solution. The mini-column was placed ln a microcentrifuge tube 
and spun for 20 seconds at 13,000 x g to dry the resin. To elute 
the DNA fragment into a new microcentrifuge tube, 50 ~l of TE 
buffer was added to the column. After 1 minute, the tube was 
spun again for 20 seconds at 13,000 x g. A gel electrophoresis 
was then performed to check for successful purification. The 
isolated plasmid, 0.8 ~g at 0.02 ~g/~l was precipitated by adding 
0.1 X volumes of 3 M NaOAc pH 5.2 (4.1 ~l) and 2.25 X volumes of 
cold absolute ethanol (92.25 ~l). After storing at -20°C for 16 
--
-
hours and centrifuging in the cold at 14,000 x g, the 
precipitated pellet was resuspended in 5.5 ~l TE buffer. 
Ligation of Isolated DNA 
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To recirculize the isolated, cut plasmid fragment, a 
"Ligation Express Kit" by Clonetech was used. The reaction 
contents included 5.5 ~l plasmid in TE, 27.5 ~l buffer, 3.3 ~l 
ATP (10 mM), and 2. 75 ~l T4 DNA Ligase (100 U/~l) to <;Jive a 39 ~l 
total volume in the microcentrifuge tube. This reaction was run 
for 30 minutes at 16°C Upon completion, 2.67 ~l glycogen (20 
~g/~l), 85.0 ~l nuclease free H20, and 250 ~l absolute ethanol 
were all added. After storing at -70°C for 40 minutes, the 
microcentrifuge tube was centrifuged at 13,000 x g for 13 minutes 
at room temperature. The pellet was resuspended in 10 ~l 
nuclease free H20. 
Transformation of Mutant Plasmid 
2.5 ~l (375 ng) of the mutant plasmid was added to 250 ~l of 
competent E. coli cells. After incubating on ice for 15-30 
minutes, the microcentrifuge tube was placed in a 42°C water 
bath for 2 minutes. Upon returning to the ice for at least 1 
minute, 1 ml Luria broth was added. The solution was 
subsequently incubated at 37°C for 30-60 minutes. 
Five top agar tubes were meanwhile boiled and allowed to 
cool to 55 °C. Once cooled, 8 ~l of 5,000 ~g/ml ampicillin 
(Sigma Chemical Co.) and the transformed cells were both added to 
the top agar tubes. 50 ~l (2X), 75 ~l (lX), and 100 ~l (2X) of 
the transformed cells were added to 5 top agar tubes 
----
respectively. After mixing, the top agar was poured onto Luria 
broth media plates and incubated at 37 DC for 16-24 hours. 
Miniprep of Transfor.med Plasmid 
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Five tubes of Luria broth were inoculated with single 
colonies from the LB agar plates and incubated at 37 DC with 
mixing. Upon significant growth of cells (after at least 16 
hours), the cells were pelleted out by centrifugation at 2,000 x 
g for 10 minutes. Each pellet was resuspended in microcentrifuge 
tubes with 0.7 ml STET buffer pH 8.0 (8% sucrose, 5% Triton X 
100, 50 mM EDTA, and 50 mM Tris), vortexed, and incubated on ice. 
To lyse the cells, 50 ~l lysozyme at 5 ~g/~l (Sigma Chemical 
Co.) was added. After 10 minutes on ice, the cells were 
transferred to a boiling H20 bath for 1 minute. The suspension 
was subsequently centrifuged, and the supernatant removed from 
the pellet. 
An equal volume of isopropanol was added to the supernatant 
to precipitate the DNA. After gentle mixing, the suspension was 
placed in a -70 DC freezer for 12-17 minutes. The solution was 
then centrifuged in the cold for 12-15 minutes at 14,000 x g. 
The supernatant was then poured off. The pellet was next 
rinsed twice with 0.9 ml of cold 95% ethanol. The isolated DNA 
was then resuspended in 40 ~l TE buffer. 
Gel electrophoresis was used to check if colonies had taken 
up the mutant plasmid. Successful colonies were then prepared 
for storage. 250 ~l of cells were pipet ted into a 
microcentrifuge tube along with 125 ~l glycerol and 125 ~l LB 
----
broth. Five colonies were then placed at -70°C for storage. 
Polymerase Chain Reaction (PCR) 
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A PCR kit by Life Technologies was used. The following was 
added to a microcentrifuge tube: 12.5 ~l 10 X PCR buffer (200 mM 
Tris-HCl pH 8.4 and 500 mM KCl) , 3.75 ~l 20 mM dNTP ID.ixture, 3.75 
~l MgC1 2 (50 mM), 1.25 ~l primer #60, 1.25 ~l primer #70, 1.25 ~l 
Taq DNA Polymerase (5 U/~l), and 100 ~l nuclease free H20. 50 ~l 
of this mixture was added to two microcentrifuge tubes. One tube 
contained the regular pBB3.2 GS plasmid; the other was the 
control and did not contain any DNA. Both tubes were subjected 
to PCR by a thermal cycler for 40 cycles of amplification. The 
reaction parameters or steps were: [1] 94°C for 5 min. (lX), [2] 
94°C for 1 min., 42 oC for 1 min., 72°C for 1 min. (40X), [3] 
72°C for 10 min. (lX), and [4] 4 °C for the remaining time. 
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Results 
Overall Strategy 
The goal of this project was to create a mutant pBB3.2 GS-
containing plasmid. By removing a small fragment in the GS 
sequence, the RNA made from the mutant plasmid would give RT-PCR 
products easily distinguishable from RT-PCR products derived from 
endogenous DNA contamination. This was effectively accomplished 
using the restriction enzyme Bsm1 to cut out the small piece of 
DNA. The plasmid was then recirculized and amplified in 
bacteria. Upon retrieving the amplified plasmid, selection for a 
successfully mutated plasmid was done via gel electrophoresis. 
Selection of Restriction Enzymes 
Restriction enzyme analysis of the GS nucleotide sequence 
was performed on Pustell Sequence Analysis Programs version 2.03. 
Upon entering the GS sequence obtained by Hayward et al. (1986) 
into the computer, Bsm1 and Kpn1 restriction enzymes were 
determined the best two candidates for helping to create the 
mutant internal control. Kpn1 cuts the GS sequence at position 
number 995; it does not cut the Bluescript M13+ plasmid. Bsm1 
was found to cut the GS sequence at position number 1117; it does 
not cut the Bluescript M13+ plasmid. Other cutting sites on GS 
could not be ruled out for either enzyme due to no knowing the 
entire GS sequence present in the plasmid. 
Restriction Enzyme Analysis 
To further investigate the two enzymes, separate digests 
were run on the pBB3.2 GS-containing plasmid. A photograph of 
~ 
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the gel electrophoresis is shown in fig. 2. Lane 2 shows that 
only one fragment was produced upon digestion with Kpn1. Lane 3, 
however, demonstrates that two separate fragments were produced 
by Bsm1. This unexpected result is due to the presence of an 
intron. Fragment sizes of the two bands were found to be 6.557 
Kb and 0.489 Kb. 
Due to the small size of the 0.489 Kb fragment, it was 
decided that Bsm1 was the enzyme best suited for creating the 
mutant pBB3.2 plasmid. Fig.3. shows the pBB3.2 plasmid with the 
T7 and T3 promoters within the Bluescript vector. The Bsm1 
cutting sites within the GS cDNA are somewhere between the 
primers, with one cutting site at the 1117 bp position of the GS 
I sequence. The other cutting site is approximately 489 bp away. 
The Bluescript M13+ vector is 2.961 Kb, while the GS insert is 
approximately 3.2 Kb. The known GS coding sequence determined by 
cDNA is 1421 bp, excluding a primer flanking intron. The 
remaining sequence of the insert is probably additional introns, 
regulatory elements, and noncoding regions (Chatot 1995) . 
Isolation of the Large Fragment 
In order to isolate the larger 6.557 Kb piece from the 
smaller fragment generated from the restriction digest, a low-
melt gel electrophoresis of GS cut by Bsm1 was run. A photograph 
of the gel is shown in fig. 4. Both fragments were again 
produced by the Bsm1 digest. The 6.557 Kb bands from lanes 2 and 
3 were cut from the gel. 
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Purification of the Large Fragment 
Once the isolation of the plasmid without the 0.489 Kb 
fragment was complete, the DNA was purified from the low-melt 
agarose gel via a Wizard miniprep. Another gel electrophoresis 
was run to confirm the purity of the 6.557 Kb fragment. A 
photograph of the gel is shown in fig. 5. The large fragment is 
clearly visible, but the small 0.489 Kb fragment is not present. 
Amplification of the DNA 
After the isolation and purification of the large fragment 
was certain, the large fragment was ligated back together, 
transformed into bacterial cells for amplification, and isolated 
back out of the cells. A gel electrophoresis was run on the 
mutant plasmid isolated from the bacteria. A photograph is shown 
in fig. 6. All five colonies, lanes 4-8, exhibit single distinct 
bands. These bands ran slightly above the large fragment that is 
typical of regular pBB3.2 cut with Bsm1 (lane 3). This is 
explained by the gel running at a slight angle as seen by the dye 
front. An Rf value was calculated; the ratios between the DNA 
isolated by the miniprep to the dye front and the purified large 
fragment to the dye front were very similar. 
Control for PCR 
As a control for the peR of the mutant plasmid, regular GS 
was cut with EcoR1 for linearization and subjected to peR. Fig. 
7. shows the products as seen by gel electrophoresis. 
standard in lane 1 is pBR322 DNA cut by BstN1. Lane 3 
The 
is the 681 
bp peR product produced from GS using 3' antisense and 5' sense 
--
-
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primers #60 and #70. Fragment size analysis was performed from a 
different gel using the two standards, Phix174 HaeIII digest and 
pBR322 BstNl digest. 
peR of the Mutant Plasmid 
Several attempts were made to isolate the mutant plasmid 
back out of the bacterial cells for sUbjection to PCR to prove 
the successful creation of the mutant plasmid. Although 
successfully completed earlier in the study, as seen in fig. 6., 
endeavors to repeat the isolation were not successful. After 
overcoming the problem of growing the frozen, mutant plasmid 
containing cells, many Magic minipreps (Promega Corp.) were 
performed. Upon viewing by gel electrophoresis, however, no DNA 
was observed to be isolated. The protocol used in the earlier 
successful miniprep was altogether different from the Magic 
miniprep. The Magic miniprep protocol was very similar to the 
Wizard miniprep (see 'Methods'), except that cells had to first 
be lysed and pelleted. 
--
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Fig. 2. Gel electrophoresis of restriction enzyme analysis for 
GS. Lanes contain: (1) Lambda DNA cut with Hind III, (2) GS cut 
with Kpn1, (3) GS cut with Bsrn1 showing the 6.557 Kb and 0.489 Kb 
fragments, (4) Uncut GS. 
- I 
-
T7 Promoter 
Bluascript M13 + 
with 3.2 Kb Insert 
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5' Primer 
T3 Promoter 
Fig. 3. The GS insert, between the promoters, is 3.2 Kb. The 300 
bp GS-coding sequence and the intron are enclosed by both the 3' 
antisense and the 5' antisense #60 and #70 primers. A 489 bp 
fragment was removed from within the GS sequence to create the 
mutant plasmid. The pBB3.2 vector was obtained from the 
laboratory of Magnuson and Young. 
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Fig. 4. Low-melt gel electrophoresis. Lanes contain: (1) Lambda 
DNA cut with Hind III, (2 and 3) GS cut with Bsm1. Only the 
6.557 Kb piece was cut from the agarose gel for purification and 
ligation, making the GS insert 489 bp smaller. 
--
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Fig. 5. Gel electrophoresis of the isolated and purified 6.557 Kb 
fragment. Lanes contain: (1) Lambda DNA cut with Hind III, (2 
and 3) Uncut GS, (4) 6.577 Kb GS containing plasmid without the 
0.489 Kb fragment. Purification of the plasmid DNA from the 
agarose gel was done using "Wizard peR Preps" system by Promega 
Corp. as described in 'Methods'. 
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Fig. 6. Gel electrophoresis of the mutant GS plasmid isolated 
from transformed bacterial cells. Lanes contain: (l) Lambda DNA 
cut with Hind III, (2) Uncut GS, (3) GS cut with Bsml, (4-8) 
Mutant GS containing plasmid from five different bacterial 
colonies respectively. 
--
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Fig. 7. Gel electrophoresis of the GS PCR product. Lanes 
contain: (1) pBR322 DNA cut with BstN1, (2) Uncut GS, (3) PCR 
product from regular GS linearized by EcoR1, (4) Control. From 
fragment analysis, the PCR product in lane 3 was determined to be 
0.681 Kb. The control sample did not contain any DNA; it was 
subjected to PCR to be sure the product produced from the GS in 
the PCR was not an artifact from methodology or contamination. 
The very faint band in lane 4 is likely due to DNA running in 
from well 3. 
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Discussion 
The purpose of the present project was to create mutant GS 
DNA using the pBB3.2 plasmid. This altered genomic DNA will now 
be used for a variety of internal control purposes. This control 
will allow for the characterization of the expression patterns of 
GS during both in vivo and in vitro preimplantion development at 
the level of transcription. 
The utilized distinction based on size differences due to 
the removal of the 0.489 Kb fragment was not the first strategy 
used in trying to create an internal control. The first approach 
attempted to make the distinction between internal control and 
endogenous products by removing a restriction enzyme site from 
the pBB3.2 plasmid. After the RT-PCR had been performed on both 
the endogenous and the internal control plasmid, both would have 
been subjected to a Bsml restriction digest. The internal 
control plasmid would not have had the cutting site, but the 
endogenous would have been cut into two fragments making both 
endogenous and control DNA products easily distinguishable. 
The steps to crate a mutant plasmid without the Bsml 
restriction site began with a Bsml digest. The overhanging ends 
were removed by the enzyme Mung Bean nuclease, and the plasmid 
was then ligated back together. With the Bsml cutting site now 
removed, the plasmid was transformed into bacteria for 
amplification. Isolated plasmids from the bacteria were then 
checked for correct ligation by comparing the products from 
digests of the mutant and regular pBB3.2 plasmid. 
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Two problems, however, arose from this approach. Since Bsml 
produced two fragments upon digestion, there were multiple ways 
in which the plasmid could be ligated back together. Fragment 
orientation could become reversed thereby altering its 
transcription product and viability. The other perplexity lied 
in the isolation of the mutant plasmid back out of the bacteria. 
Even if most of the bacteria contained mutant plasmids that had 
ligated back together properly, there was still a chance that 
those colonies would never be picked for isolation. No 
accurately ligated plasmids were ever isolated from the bacteria. 
This time-consuming, "shot-gun" approach was abandoned for 
the more precise methodology previously described in 'Methods'. 
-I This method of removing a small fragment from the pBB3.2 plasmid 
had two advantages. Because no Mung Bean nuclease was used to 
remove the Bsml cutting site, the ends of the 6.557 Kb fragment 
were "sticky". This meant the overhanging ends would ligate back 
together much more efficiently and only in the correct 
orientation. This eliminated chance from the experiment. 
The other advantage is inherent to the mutant plasmid. 
Because the size difference is present before experiments are 
run, no diagnostic restriction digestion prior to gel 
electrophoresis will have to be used after RT-PCR to distinguish 
between products. 
The mutant GS plasmid will first be used to synthesize 
measurable quantities of GS specific RNA transcripts to be used 
as an internal control. A specific concentration of internal 
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control RNA will be determined that is comparable to i-cell and 
blastocyst RNA expression. The optimal number of PCR cycles will 
also be obtained. This concentration and number of cycles will 
then be used in subsequent experiments. 
Experimental design of future experiments will first require 
RNA extraction from in vivo and in vitro (CZB media) grown 
embryos at the 1-, 2-, 4-, 8-16-, and blastocyst stages. The 
internal control RNA will be added to the embryo samples before 
RNA extraction and RT-PCR are performed. RT-PCR, Rev"erse 
Transcriptase-Polymerase Chain Reaction, synthesizes new cDNA 
from RNA and subsequently amplifies the newly created cDNA. RT-
PCR analysis will be used because of its high sensitivity, 
relatively low cost, and low number of required embry"os. RT-PCR 
will give products indicative of associated GS expression. 
Because each sample will contain both the mutant control and 
the endogenous RNA, questions of efficiency of primers and 
variations between reactions and experiments can be eliminated. 
The products from the RT-PCR reactions will be run on a gel 
electrophoresis and analyzed by density scanning on the Southern 
Blots. In summary, the created mutant plasmid will be used as an 
internal control for RNA yield and gel loading controls in RNA 
extractions and RT-PCR reactions. (Chatot 1995) 
If just the regular pBB3.2 plasmid containing the GS insert 
was used as an internal control, there would be no way of 
distinguishing its products from endogenous or control tissue 
products resulting from DNA contamination. The established 
--
-
mutant plasmid will now allow for this distinction, due to 
product size differences. 
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It has previously been determined, based on primer design, 
that mouse brain RNA produces a PCR product 300 bp long (Chatot 
1995). Normal pBB3.2 containing the GS insert was linearized 
with EcoRl, which cuts the plasmid once. It was then subjected 
to PCR. Upon product analysis by gel electrophoresis, the PCR 
product was determined to be 681 bp (fig.7), not the expected 300 
bp. This 681 bp fragment represents a 381 bp intron present 
within the GS insert. 
The intron's presence was also exhibited by the two 
fragments that were produced upon Bsm1 digestion. Bsm1 only cuts 
the known GS sequence once and does not cut the plasmid. The 
unexpected two fragments could only be due to a restriction site 
present in the unknown sequence of an intron. 
RT-PCR products from experiments will be analyzed uSlng the 
above known product sizes. Endogenous RNA should give a 300 bp 
product. Internal control should yield a 192 bp product due to 
the removal of the 489 bp fragment. DNA contamination will be 
exhibited by a 681 bp product. The intron is still present in 
the DNA, but not in the RNA. This is a critical quality control 
for the RNA extraction. The endogenous DNA would compete for 
primers and other reactants during the PCR and thus affect the 
efficiency of the RNA amplification. 
The pattern of GS expression for both in vivo and in vitro 
will likely follow previously studied preimplantation genes. For 
~ 
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glutaminase (GA), which converts glutamine to glutamate, mRNA 
expression has shown a decrease from the I-cell to early 2-cell 
stage. A subsequent and sustained increase is expressed from 
late 2-cell to blastocyst stage (Chatot and Kamper 1992). Many 
other preimplantation genes, including genes for actin and 
histone, as previously described, also show this same pattern of 
expression (Kidder 1993). 
The characterization of GS expression both in vivo and in 
vitro will aid in defining a set of parameters for normal mouse 
preimplantation development and in improving embryo culture 
conditions. The closer the culture conditions are in modeling In 
vivo conditions, the easier it will be to study what is actually 
I occurring in the mouse embryo. If the similarity in expression 
for GS is established between in vivo and in vitro grown embryos, 
the evaluation of the effect of a putative teratogen on GS 
expression and embryo development can occur. (Chatot 1995) 
--
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